Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Aiora Cenigaonandia‐Campillo"'
Autor:
Aiora Cenigaonandia‐Campillo, Ana Garcia‐Bautista, Anxo Rio‐Vilariño, Arancha Cebrian, Laura delPuerto, José Antonio Pellicer, José Antonio Gabaldón, Horacio Pérez‐Sánchez, Miguel Carmena‐Bargueño, Carolina Meroño, Javier Traba, María Jesús Fernandez‐Aceñero, Natalia Baños‐Herraiz, Lorena Mozas‐Vivar, Estrella Núñez‐Delicado, Jesús Garcia‐Foncillas, Óscar Aguilera
Publikováno v:
Molecular Oncology, Vol 18, Iss 9, Pp 2212-2233 (2024)
In pancreatic ductal adenocarcinoma (PDAC), metabolic rewiring and resistance to standard therapy are closely associated. PDAC cells show enormous requirements for glucose‐derived citrate, the first rate‐limiting metabolite in the synthesis of ne
Externí odkaz:
https://doaj.org/article/15680545600940349d1f3088fd3a5d0b
Autor:
Jesús García-Foncillas, Óscar Aguilera, Roberto Serna-Blasco, Natalia Baños-Herraiz, Sonia Solanes-Casado, Aiora Cenigaonandia-Campillo, María Jesús Fernández Aceñero, Laura del Puerto-Nevado, Jose Antonio Cañas, Laura Gómez-Ocabo
Publikováno v:
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Theranostics
instname
Theranostics
Background: In hypoxic tumors, positive feedback between oncogenic KRAS and HIF-1α involves impressive metabolic changes correlating with drug resistance and poor prognosis in colorectal cancer. Up to date, designed KRAS-targeting molecules do not s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a25836263c8c94daddedf3a8cf3c9d2d
https://pubmed.ncbi.nlm.nih.gov/33664850
https://pubmed.ncbi.nlm.nih.gov/33664850